Mayinglong Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -1.64% vs 16.79% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 153.53% vs -46.57% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,012.40",
          "val2": "1,029.30",
          "chgp": "-1.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "237.70",
          "val2": "123.00",
          "chgp": "93.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "2.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.30",
          "val2": "-19.20",
          "chgp": "122.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "219.30",
          "val2": "86.50",
          "chgp": "153.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "234.80%",
          "val2": "95.30%",
          "chgp": "13.95%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.79% vs 18.93% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.47% vs 21.36% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,842.00",
          "val2": "3,701.70",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "744.90",
          "val2": "674.70",
          "chgp": "10.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.60",
          "val2": "15.00",
          "chgp": "-9.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.60",
          "val2": "-11.80",
          "chgp": "35.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "605.70",
          "val2": "548.30",
          "chgp": "10.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "168.30%",
          "val2": "158.90%",
          "chgp": "0.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,012.40

1,029.30

-1.64%

Operating Profit (PBDIT) excl Other Income

237.70

123.00

93.25%

Interest

1.10

2.20

-50.00%

Exceptional Items

4.30

-19.20

122.40%

Consolidate Net Profit

219.30

86.50

153.53%

Operating Profit Margin (Excl OI)

234.80%

95.30%

13.95%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -1.64% vs 16.79% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 153.53% vs -46.57% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,842.00

3,701.70

3.79%

Operating Profit (PBDIT) excl Other Income

744.90

674.70

10.40%

Interest

13.60

15.00

-9.33%

Exceptional Items

-7.60

-11.80

35.59%

Consolidate Net Profit

605.70

548.30

10.47%

Operating Profit Margin (Excl OI)

168.30%

158.90%

0.94%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.79% vs 18.93% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 10.47% vs 21.36% in Dec 2024

All Annual Results